BVF Inc’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,484,674
Closed -$88.8M 65
2020
Q2
$88.8M Sell
1,484,674
-98,921
-6% -$6.11M 5.47% 2
2020
Q1
$94M Sell
1,583,595
-133,139
-8% -$7.76M 8.76% 1
2019
Q4
$94M Buy
+1,716,734
New +$64.1M 7.13% 4
2019
Q1
Sell
-146,300
Closed -$4.01M 56
2018
Q4
$4.01M Sell
146,300
-93,700
-39% -$2.41M 0.52% 42
2018
Q3
$7.01M Buy
+240,000
New +$6.77M 0.62% 42

Other funds holding PRNB

BVF Inc's PRNB Position: Q3 2020 in Review

BVF Inc sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,484,674 shares — an estimated $88.8M sold.

BVF Inc first reported a position in PRNB in Q3 2018 and held it in 5 quarters. The position peaked at $94M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • BVF Inc reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • BVF Inc sold 1,484,674 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $88.8M.
  • BVF Inc first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • BVF Inc's Principia Biopharma Inc. Common Stock position peaked at $94M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on BVF Inc's 13F filing for Q3 2020, filed 13 Nov 2020.